CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

ERS 2026: obesity, an independent obstruction to biologic-treated asthma

ConferenceNeutral
AI Analysis

Summary

At ERS 2026, investigators presented findings on the relationship between BMI and treatment outcomes in severe asthma patients receiving biologic therapies.

Importance:2/10
Sentiment:
0.00
asthmaobesitybiologicsERS 2026clinical research

Read the original article

Published by Pharmaceutical Technology on September 16, 2026 9:39 AM

Read Original